The call was for biomed scientists and investors to apply for a new startup focused on AI-designed antibody therapies.

AION Labs, is a first-of-its-kind innovation lab spearheading the adoption of AI technologies and computational science

The innovation lab, which will also include pharma companies Merck, and Teva, will research digital health and computational biology.

The company and its partners plan to invest in up to four early-stage Israeli startups a year over five years